Catalyst Wire Dossier Catalyst Wire Dossier

HP-5000

· Noven Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HP-5000, covering 2021-12-23 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee [Phase 3]

See pricing